Change in Legislature: Possibilities of CBD in Medicine — and Skincare

Over the past decade, the legal landscape around cannabis and cannabinoids has shifted significantly in the United States. As policymakers adjust federal and state frameworks around cannabis and hemp-derived compounds like cannabidiol (CBD), new opportunities are emerging not just for medical research, but also for skincare innovation. These changes could influence how scientists, clinicians, and consumers approach CBD — from clinical studies to daily routines.

Why the Legal Landscape Is Evolving

Historically, cannabis and its constituent compounds were classified under restrictive federal drug schedules, limiting scientific investigation and clinical research. Although hemp-derived CBD with very low levels of THC became legal federally under the 2018 Farm Bill, clinical research remained constrained by regulatory barriers and complex state-level laws.

More recent legislative action — including shifts in federal scheduling and directives to facilitate medical research — has begun to lower those barriers. This means more scientists can design controlled studies, and clinicians can engage with cannabinoid science in ways that were previously difficult. The result? A clearer understanding of how cannabinoids like CBD might function in medicine and wellness.

These legislative changes are opening doors for:

• Rigorous clinical research

• Expanded therapeutic exploration

• Better regulatory frameworks and product quality standards

CBD and the Endocannabinoid System: What Research Shows

One of the most discussed scientific frameworks for understanding CBD is the endocannabinoid system (ECS) — a network of receptors and signaling molecules present throughout the body, including the skin.

The ECS plays a role in regulating:

• Inflammation and immune responses

• Pain signaling

• Cell growth and repair

• Skin barrier function

• Oil production and moisture retention

Research suggests that cannabinoids like CBD interact with ECS receptors in ways that may promote equilibrium in physiological processes. In the context of the skin, this has important implications for conditions associated with dryness, irritation, and impaired barrier function:

Skin Barrier and HydrationThe skin’s outermost layer — the stratum corneum — is critical for retaining moisture and protecting against environmental stressors. Some studies indicate that endocannabinoid signaling can influence lipid production and cell communication within the skin, which may support moisture balance and barrier integrity.

Inflammation and SensitivityInflammation is a common component of many dry, irritated skin conditions. CBD has been the subject of research exploring its effects on inflammatory pathways. While research is still emerging, laboratory and early clinical data show promise in how CBD may influence inflammatory mediators in skin cells.

It’s important to emphasize that research is ongoing, and while many preliminary findings are promising, robust clinical trials are still needed to define precise mechanisms, optimal formulations, and dosing strategies.

What This Means for CBD in Skincare

As regulatory barriers to cannabinoid research diminish, our understanding of how CBD interacts with human biology — including the ECS and skin function — continues to deepen. This evolving science could expand how skincare is conceptualized, moving beyond cosmetic effects to physiological modulation at the skin level.

From a formulation perspective, this has led to products that aim to:

• Support moisture retention

• Help regulate skin responses

• Offer a calming effect for stressed or dry skin

Butterfly High’s Perspective

At Butterfly High, we believe that skincare should be built on a foundation of biology, clarity, and careful formulation — not buzzwords or trends.

Our approach to CBD in skincare is guided by the current evidence and the potential of the endocannabinoid system to support skin health. We formulate with CBD in ways that:

• Emphasize skin barrier support, not sensational claims

• Pair CBD with complementary, clean ingredients

• Focus on balanced hydration and resilience

We do not make medical claims about any specific clinical outcomes; instead, we craft with intention based on what biology tells us about how the skin functions. Our goal is to support the skin’s natural processes in a way that feels refined and effective for daily use.

Where Science and Skincare May Go Next

With legislative changes facilitating more cannabinoid research, the future of CBD in medicine — and in dermatological research — is promising:

• Researchers may explore CBD’s potential in chronic inflammatory conditions

• Clinical trials may clarify how cannabinoids influence skin aging, barrier repair, and sensitivity

• Regulatory bodies may establish clearer standards for quality and efficacy in skincare formulations

As the legal framework evolves, so too will the evidence base — offering greater clarity for clinicians, formulators, and consumers alike.

---

The landscape of CBD research is rapidly evolving. Legislative change is lowering barriers to medical research, which deepens our ability to understand how cannabinoids interact with human physiology, including the endocannabinoid system. For skincare, this translated potential lies in supporting the skin’s natural balance through thoughtful formulation and biology-aligned ingredients.

At Butterfly High, we’re watching these developments closely and committed to applying emerging evidence with integrity — creating products that are as sophisticated in design as they are grounded in science.